Drug Product Listings

Please note - this is not a complete list of products available in Canada. For a complete list of drug products marketed in Canada, visit the Health Canada Drug Product Database
A (35) | B (19) | C (21) | D (34) | E (35) | F (11) | G (9) | H (9) | I (21) | K (1) | L (24) | M (12) | N (6) | O (10) | P (27) | R (14) | S (24) | T (26) | U (3) | V (12) | W (1) | Z (4)
Generic Name Common Trade Name(s)sort icon Classification Date Marketed in Canada (yyyy/mm/dd)
Asunaprevir Sunvepra Antiviral agent 2016/04/22
Ibuprofen & Methocarbamol Summit Ultra Muscle relaxant/analgesic 2012/03/14
Methocarbamol & Ibuprofen Summit Ultra Muscle relaxant/analgesic 2012/03/14
Buprenorphine Sublocade Partial opioid agonist 2019
Zolpidem Sublinox Hypnotic 2011-12-07
Ivermectin Stromectol Anthelmintic 2018/11/07
Elvitegravir + Cobicistat + Emtricitabine + Tenofovir disoproxil fumarate Stribild Antiretroviral agent 2012/12/20
Regorafenib Stivarga Antineoplastic agent 2013/03/11
Ertugliflozin + sitagliptin Steglujan Oral blood glucose lowering agents 2018/05/22
Ertugliflozin Steglatro Sodium-glucose co-transporter 2 (SGLT2) inhibitor 2018/05/23
Vardenafil Staxyn Phosphodiesterase Type 5 Inhibitor 2011/08/29
Levodopa, carbidopa, entacapone Stalevo Anti-parkinson drugs 2010/08/03
Esketamine Spravato Antidepressant 2020/05/20
Eculizumab Soliris Humanized monoclonal antibody 2009/06/29
Risankizumab Skyrizi Interleukin-23 inihbitor 2019/05/13
Tedizolid Sivextro Oxazolidinone antibiotic 2015/10/08
Golimumab Simponi Tumor necrosis factor alpha inhibitor (DMARD) 2009/07
Doxepin Silenor Hypnotic 2012/01/08
Pasireotide Signifor Synthetic analogue of somatostatin 2013/11/26
Ertugliflozin + metformin Segluromet Oral blood glucose lowering agents 2018/05/30
Glycopyrronium bromide Seebri Breezhaler Anticholinergic agent 2013/01/29
Ethinyl estradiol + levonorgestrel Seasonique Oral contraceptive 2011/04/15
Liraglutide Saxenda Incretin mimetic 2015/05/27
Asenapine Saphris Atypical antipsychotic 2012/03/16
Tolvaptan Samsca Vasopressin V2 receptor antagonist 2011/09/22
Semaglutide Rybelsus Incretin mimetic 2020/04/19
Rupatadine Rupall Antihistamine, second generation 2017/01/25
Ivermectin Rosiver Topical rosacea therapy 2015/05/25
Calcitriol Rocaltrol oral solution Vitamin D analogue
Upadacitinib Rinvoq Disease-modifying antirheumatic agent 2020/01/16
Brexpiprazole Rexulti Antipsychotic agent 2017/04/20
Eltrombopag Revolade Thrombopoietin receptor antagonist 2011/0404
Lenalidomide Revlimid Antineoplastic agent
Sildenafil citrate Revatio IV cGMP-Specific Phosphodiesterase Type 5 Inhibitor 2010/08/31
Cyclosporine Restasis Topical immunomodulator with anti-inflammatory effects 2010/10
Prucalopride Resotran Enterokinetic agent 2012/01/13
Syndicate content